| 000 | 03251nam a22003495i 4500 | ||
|---|---|---|---|
| 999 |
_c80450 _d80450 _x1 |
||
| 001 | 80450 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040306.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 140816s2014 gw | s |||| 0|eng d | ||
| 020 | _a9783540367192 | ||
| 024 | 7 |
_a10.1007/978-3-540-36719-2 _2doi |
|
| 040 | _dES-MaUEC | ||
| 050 | 4 |
_aR895 _b.T447 2014 |
|
| 245 | 1 | 0 |
_aTherapeutic Nuclear Medicine _cedited by Richard P. Baum. |
| 260 |
_aBerlin, Heidelberg _bSpringer International Publishing _c2014 |
||
| 300 |
_a1 recurso en línea (XVIII, 951 p.) _b600 ilustraciones, 300 ilustraciones en color |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aMedical Radiology _x0942-5373 |
|
| 505 | 0 | _aPART I: Basic Principles (11 chapters) -- PART II: Clinical Applications: Brain and Nasopharyngeal Tumors (4 chapters).-Thyroid Cancer (11 chapters) -- Benign Thyroid Diseases (2 chapters) -- Primary and Metastatic Liver Cancer (5 chapters) -- Bone and Joint Disease (5 chapters) -- Hematological Malignancies (8 chapters) -- Endocrine Tumors (2 chapters) -- Radioimmunotherapy (7 chapters) -- Intravascular/Intracavitary/Interstitial and Epidemal RadionuclideTherapy (5 chapters) -- PART III: Radiation Biology and Dosimetry (11 chapters) -- PART IV: Radiation Planning and Perspectives of Radionuclide Therapy (10 chapters) -- Subject Index. | |
| 520 | _aThe recent revolution in molecular biology offers exciting new opportunities for targeted radionuclide therapy. The selective irradiation of tumor cells through molecular biological mechanisms is now permitting the radiopharmaceutical control of tumors that are unresectable and unresponsive to either chemotherapy or conventional radiotherapy. In this up-to-date, comprehensive book, world-renowned experts discuss the basic principles of radionuclide therapy, explore in detail the available treatments, explain the regulatory requirements, and examine likely future developments. The full range of clinical applications is considered, including thyroid cancer, hematological malignancies, brain tumors, liver cancer, bone and joint disease, and neuroendocrine tumors. The combination of theoretical background and practical information will provide the reader with all the knowledge required to administer radionuclide therapy safely and effectively in the individual patient. Careful attention is also paid to the important role of the therapeutic nuclear physician in delivering the effective coordination of a diverse multidisciplinary team that is essential to the safe provision of treatment. | ||
| 650 | 7 |
_aMedicina nuclear _2embne _9138396 |
|
| 700 | 1 |
_aBaum, Richard P. _eeditor literario _0Local _988636 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-540-36719-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b12882033 _b10-10-17 _c11-11-15 |
||
| 942 |
_2lcc _cLE |
||
| 945 |
_aR895 .T447 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11561853 _z06-04-17 |
||
| 988 | _aEBSPRINGER | ||
| 998 |
_am _a_alco _a_vill _b11-11-15 _cm _dz _e- _feng _ggw _h0 |
||